Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Oncology | Pediatrics/Neonatology | Musculoskeletal
Rhabdomyosarcoma Clinical Trials
A listing of Rhabdomyosarcoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Georgia
Memorial University Medical Center
ARST0531: Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating with Vincristine and Irinotecan (VI) for Patient with Intermediate-Risk Rhabdomyosarcoma (RMS)
Memorial University Medical Center
ARST0921: A Randomized Phase II Trial of Bevacizumab (IND#7921, Avastin) and Temsirolimus (IND#61010, Torisel) in Combination with Intravenous Vinorelbine and Cyclophosphamide in Patients with Recurrent/Refractory Rhabdomyosarcoma
View More »
Children's Healthcare of Atlanta Childern Hosp - ATL
Patients are needed to participate in a clinical research study of LDE225
Maryland
Massachusetts
Dana Farber Cancer Institute DFCI (3)
Patients are needed to participate in a clinical research study of LDE225
Oregon
OHSU Knight Cancer Institute
Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
Washington
Seattle Children's Hospital CPKC412A2114
Patients are needed to participate in a clinical research study of LDE225
Australia
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Austria
Medical University Vienna - General Hospital
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Belgium
Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
U.Z. Gasthuisberg
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Bulgaria
Teva Investigational Site 0103
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0101
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0102
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Canada
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Czech Republic
Teva Investigational Site 0201
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
France
Institut Bergonie
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Centre Georges-Francois-Leclerc
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Centre Leon Berard
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Assistance Publique - Hôpitaux de Marseille - Hôpital de La Timone
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Institut Gustave Roussy
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Germany
Helios Klinikum Bad Saarow
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Universitaetsklinikum - Essen
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
UniversitaetsMedizin Mannheim
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Klinikum Grosshadern Ludwig-Maximilians Univ. Muenchen
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Hungary
Teva Investigational Site 0301
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Italy
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Fondazione IRCCS Istituto Nazionale dei Tumori
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LDE225
Netherlands
Leiden University Medical Centre
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Norway
Oslo University Hospital - Radiumhospitalet
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Poland
Teva Investigational Site 0401
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Russian Federation
Teva Investigational Site 0501
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0504
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0507
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0505
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0502
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Slovakia
National Cancer Institute
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Slovenia
The Institute Of Oncology
Patients are needed to participate in a clinical research study evaluating Crizotinib (PF-02341066)
Ukraine
Teva Investigational Site 0701
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0705
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0702
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0704
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
Teva Investigational Site 0703
Patients are needed to participate in a clinical research study evaluating Lipegfilgrastim for the treatment of Ewing Family of Tumors, Rhabdomyosarcoma
